-
Lexicon Shares Jump 20 Percent Following Positive Results From Mid-Stage Diabetic Neuropathy Study
Wednesday, June 29, 2022 - 4:40pm | 275Lexicon Pharmaceuticals (NASDAQ: LXRX) reported positive topline results from the Phase 2 proof-of-concept study of its lead candidate LX9211 in painful diabetic neuropathy. The RELIEF-DPN-1 is the first of two Phase 2 proof-of-concept study designed to evaluate LX9211 in patients with neuropathic...
-
SciSparc And Polyrizon Report Joining Forces To Develop A Non-Opioid Pain Relief Nasal Spray
Tuesday, June 28, 2022 - 9:53am | 1207The opioid crisis has raised public awareness about the dire state of pain-management options for the estimated 50 million Americans with chronic pain. As the crisis renews the call for researchers to find a pain relief method that is both powerful and safe, some pharmaceutical companies like...
-
US Expands Monkeypox Testing Capacity To Five Commercial Lab Companies
Thursday, June 23, 2022 - 7:20am | 343The Department of Health and Human Services (HHS), through the Centers for Disease Control and Prevention (CDC), started shipping monkeypox tests to five commercial laboratory companies to increase monkeypox testing capacity and access. The companies include Aegis Science, Laboratory...
-
Executives Sell Around $12M Of 3 Stocks
Tuesday, June 21, 2022 - 8:23am | 529U.S. stock futures traded higher this morning on Tuesday after recording losses in the previous week. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced...
-
10 Biggest Price Target Changes For Tuesday
Tuesday, June 7, 2022 - 8:23am | 419Keybanc cut Coupa Software Incorporated (NASDAQ: COUP) price target from $125 to $100. Coupa Software shares rose 0.9% to $72.74 in pre-market trading. SVB Leerink reduced Vincerx Pharma, Inc. (NASDAQ: VINC) price target from $19 to $6. Vincerx Pharma shares rose 1.1% to close at $1.83 on...
-
10 Biggest Price Target Changes For Monday
Monday, June 6, 2022 - 7:45am | 415Citigroup cut PVH Corp. (NYSE: PVH) price target from $94 to $73. PVH shares fell 0.7% to close at $71.96 on Friday. Piper Sandler reduced JOANN Inc. (NASDAQ: JOAN) price target from $11 to $6. JOANN shares fell 0.8% to $6.31 in pre-market trading. HC Wainwright & Co. lowered the price...
-
Mid-Afternoon Market Update: Gold Drops 1%; Sprague Resources Shares Spike Higher
Friday, June 3, 2022 - 2:31pm | 790U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 300 points on Friday. The Dow traded down 0.89% to 32,953.50 while the NASDAQ fell 2.44% to 12,016.38. The S&P also fell, dropping, 1.52% to 4,113.52. Also check this: Home Depot And 2 Other Stocks...
-
Mid-Day Market Update: Nasdaq Down 300 Points; Turning Point Therapeutics Shares Jump
Friday, June 3, 2022 - 12:08pm | 812U.S. stocks extended losses midway through trading, with the Nasdaq Composite dropping more than 300 points on Friday. The Dow traded down 0.99% to 32,919.61 while the NASDAQ fell 2.61% to 11,995.68. The S&P also fell, dropping, 1.66% to 4,107.48. Also check this: Home Depot And 2 Other Stocks...
-
40 Stocks Moving In Friday's Mid-Day Session
Friday, June 3, 2022 - 12:07pm | 1270Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share. Energy Focus, Inc. (NASDAQ: EFOI) shares jumped 32.8% to $1.4740 after declining around 9% on Thursday....
-
Mid-Morning Market Update: Markets Open Lower; US Economy Adds 390,000 Jobs In May
Friday, June 3, 2022 - 10:18am | 841U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Friday. Following the market opening Friday, the Dow traded down 0.47% to 33,093.44 while the NASDAQ fell 1.49% to 12,132.82. The S&P also fell, dropping, 1% to 4,135.19. Also check this: Home Depot And 2...
-
Executives Sell Over $100M Of 4 Stocks
Wednesday, June 1, 2022 - 8:44am | 677Gold futures traded lower this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go...
-
NOVN: First EPI Sales
Saturday, May 28, 2022 - 5:11am | 2147By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT First Quarter 2022 Results On May 16, 2022, Novan Inc. (NASDAQ: NOVN) reported first quarter financial and operational results in a press release and the filing of Form 10-Q. A conference call and webcast were held that...
-
71 Biggest Movers From Yesterday
Friday, May 20, 2022 - 4:27am | 2407Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia. VivoPower International PLC (NASDAQ:...
-
38 Stocks Moving In Thursday's Mid-Day Session
Thursday, May 19, 2022 - 12:31pm | 1370Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia. Grab Holdings Limited (NASDAQ: GRAB) gained 26.1% to $3....
-
FDA Gives Nod To First Nonprescription COVID-19 Test That Also Detects Flu, RSV
Tuesday, May 17, 2022 - 7:29am | 274The FDA has authorized the first nonprescription test to detect Covid-19, influenza, and respiratory syncytial virus (RSV). The test, called the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test, was developed by Laboratory Corp of America Holdings (NYSE: LH). It can be sold...